<DOC>
	<DOCNO>NCT00628121</DOCNO>
	<brief_summary>GnRH analog globally use assist reproduction infertile patient . To date , healthy female volunteer pharmacokinetic pharmacodynamic profile cetrorelix administer single dose investigated study conduct use dos 1 , 3 5 mg. Studies perform premenopausal female volunteer confirm cetrorelix rapidly suppress luteinizing hormone ( LH ) estradiol show dose-dependent prolongation duration LH suppression . However , report study relationship cetrorelix dosage effect LH surge . In present study , investigated effect cetrorelix LH surge drug administer single dos 1 , 2 3 mg .</brief_summary>
	<brief_title>Clinical Pharmacological Study GnRH Antagonist , Cetrorelix Healthy Female Volunteer</brief_title>
	<detailed_description>To evaluate effect LH surge , investigate efficacy cetrorelix delay start LH surge comparison control menstrual cycle saline administer , also examine mode disappearance pulsatile LH secretion cetrorelix administration menstrual cycle .</detailed_description>
	<mesh_term>Cetrorelix</mesh_term>
	<criteria>BMI 18 year old &lt; 18 25 year old &gt; 25 menstrual cycle within range 25~31 day use drug ( e.g. , oral contraceptive , drug treatment hyperprolactinemia , GnRH agonists , sex steroid hormone , psychoactive drug , etc . ) serious disease endocrine system , liver , kidney , heart , lung , digestive system , etc . generalize drug allergy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>infertility , menstrual cycle , LH surge</keyword>
</DOC>